217 related articles for article (PubMed ID: 11679130)
21. Prevalence of Schistosoma mono- and co-infections with multiple common parasites and associated risk factors and morbidity profile among adults in the Taabo health and demographic surveillance system, South-Central Côte d'Ivoire.
Bassa FK; Eze IC; Assaré RK; Essé C; Koné S; Acka F; Laubhouet-Koffi V; Kouassi D; Bonfoh B; Utzinger J; N'Goran EK
Infect Dis Poverty; 2022 Jan; 11(1):3. PubMed ID: 34983662
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period.
Senghor B; Diaw OT; Doucoure S; Sylla SN; Seye M; Talla I; Bâ CT; Diallo A; Sokhna C
Parasit Vectors; 2015 Jul; 8():362. PubMed ID: 26156522
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
24. Sustaining Control of Schistosomiasis Mansoni in Western Côte d'Ivoire: Results from a SCORE Study, One Year after Initial Praziquantel Administration.
Assaré RK; Tian-Bi YN; Yao PK; N'Guessan NA; Ouattara M; Yapi A; Coulibaly JT; Meïté A; Hürlimann E; Knopp S; Utzinger J; N'Goran EK
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004329. PubMed ID: 26789749
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization and distribution of Schistosoma cercariae collected from naturally infected bulinid snails in northern and central Côte d'Ivoire.
Tian-Bi YT; Webster B; Konan CK; Allan F; Diakité NR; Ouattara M; Salia D; Koné A; Kakou AK; Rabone M; Coulibaly JT; Knopp S; Meïté A; Utzinger J; N'Goran EK; Rollinson D
Parasit Vectors; 2019 Mar; 12(1):117. PubMed ID: 30890180
[TBL] [Abstract][Full Text] [Related]
27. Effect of an integrated intervention package of preventive chemotherapy, community-led total sanitation and health education on the prevalence of helminth and intestinal protozoa infections in Côte d'Ivoire.
Hürlimann E; Silué KD; Zouzou F; Ouattara M; Schmidlin T; Yapi RB; Houngbedji CA; Dongo K; Kouadio BA; Koné S; Bonfoh B; N'Goran EK; Utzinger J; Acka-Douabélé CA; Raso G
Parasit Vectors; 2018 Feb; 11(1):115. PubMed ID: 29486790
[TBL] [Abstract][Full Text] [Related]
28. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
[TBL] [Abstract][Full Text] [Related]
29. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
Keiser J; Silué KD; Adiossan LK; N'Guessan NA; Monsan N; Utzinger J; N'Goran EK
PLoS Negl Trop Dis; 2014 Jul; 8(7):e2975. PubMed ID: 25033291
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of praziquantel on Schistosoma haematobium and re-infection rates among school-going children in the Ndumo area of uMkhanyakude district, KwaZulu-Natal, South Africa.
Kabuyaya M; Chimbari MJ; Manyangadze T; Mukaratirwa S
Infect Dis Poverty; 2017 Apr; 6(1):83. PubMed ID: 28385154
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a novel micro-sampling device, Mitra™, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural Côte d'Ivoire.
Kovač J; Panic G; Neodo A; Meister I; Coulibaly JT; Schulz JD; Keiser J
J Pharm Biomed Anal; 2018 Mar; 151():339-346. PubMed ID: 29413983
[TBL] [Abstract][Full Text] [Related]
32. Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries.
Ezeamama AE; He CL; Shen Y; Yin XP; Binder SC; Campbell CH; Rathbun S; Whalen CC; N'Goran EK; Utzinger J; Olsen A; Magnussen P; Kinung'hi S; Fenwick A; Phillips A; Ferro J; Karanja DM; Mwinzi PN; Montgomery S; Secor WE; Hamidou A; Garba A; King CH; Colley DG
BMC Infect Dis; 2016 May; 16():229. PubMed ID: 27230666
[TBL] [Abstract][Full Text] [Related]
33. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
Mwanakasale V; Vounatsou P; Sukwa TY; Ziba M; Ernest A; Tanner M
Am J Trop Med Hyg; 2003 Oct; 69(4):420-8. PubMed ID: 14640503
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
35. Effect of deworming on school-aged children's physical fitness, cognition and clinical parameters in a malaria-helminth co-endemic area of Côte d'Ivoire.
Hürlimann E; Houngbedji CA; N'Dri PB; Bänninger D; Coulibaly JT; Yap P; Silué KD; N'Goran EK; Raso G; Utzinger J
BMC Infect Dis; 2014 Jul; 14():411. PubMed ID: 25060173
[TBL] [Abstract][Full Text] [Related]
36. Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d'Ivoire.
Angora EK; Vangraefschepe A; Allienne JF; Menan H; Coulibaly JT; Meïté A; Raso G; Winkler MS; Yavo W; Touré AO; N'Goran EK; Zinsstag J; Utzinger J; Balmer O; Boissier J
Parasite; 2022; 29():23. PubMed ID: 35522066
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for schistosomiasis in an urban area in northern Côte d'Ivoire.
M'Bra RK; Kone B; Yapi YG; Silué KD; Sy I; Vienneau D; Soro N; Cissé G; Utzinger J
Infect Dis Poverty; 2018 May; 7(1):47. PubMed ID: 29773076
[TBL] [Abstract][Full Text] [Related]
38. Reduction in the prevalence and intensity of hookworm infections after praziquantel treatment for schistosomiasis infection.
Utzinger J; Vounatsou P; N'Goran EK; Tanner M; Booth M
Int J Parasitol; 2002 Jun; 32(6):759-65. PubMed ID: 12062494
[TBL] [Abstract][Full Text] [Related]
39. A six-year follow-up of schoolchildren for urinary and intestinal schistosomiasis and soil-transmitted helminthiasis in Northern Tanzania.
Poggensee G; Krantz I; Nordin P; Mtweve S; Ahlberg B; Mosha G; Freudenthal S
Acta Trop; 2005 Feb; 93(2):131-40. PubMed ID: 15652327
[TBL] [Abstract][Full Text] [Related]
40. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
